Galenical form for the administration of active ingredients by transmucous means
US10758479B2 · kind B2 · utility
0Cited by
5References
21Claims
0Family size
Inventors
Key dates
| Filing date | Sep 21, 2007 |
| Grant date | Sep 1, 2020 |
| Priority date | — |
| Expiry date | Oct 3, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A galenical form for the administration transmucously of at least one active ingredient, characterized in that the active ingredient is in a stable and complete dissolved state in a hydroalcoholic solution that includes at least 20% by mass of alcohol so as to allow rapid absorption of the active ingredient through the mucous membranes of the buccal cavity and/or the oropharynx. Uses of the galenical form are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.